(NASDAQ: MDRX) Veradigm's forecast annual revenue growth rate of -4.03% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 11.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.51%.
Veradigm's revenue in 2023 is $837,191,000.On average, 3 Wall Street analysts forecast MDRX's revenue for 2023 to be $69,998,368,092, with the lowest MDRX revenue forecast at $68,352,915,866, and the highest MDRX revenue forecast at $72,597,658,163. On average, 3 Wall Street analysts forecast MDRX's revenue for 2024 to be $74,011,479,665, with the lowest MDRX revenue forecast at $72,089,600,205, and the highest MDRX revenue forecast at $77,562,422,385.
In 2025, MDRX is forecast to generate $82,568,705,321 in revenue, with the lowest revenue forecast at $82,568,705,321 and the highest revenue forecast at $82,568,705,321.